send to a friend by email

JPH posts net income of $7.02 million in 2023

2024-02-19

According to financial statements of Jerusalem Pharmaceuticals Company JPH for the year 2023, Net profit after tax of the period reached 7,023,172 USD Compared with Net profit after tax 7,002,217 USD for 2022, a net increase in profit of 0.30%.Total assets of the company reached 85,127,994 USD compared with total assets of 83,723,210 USD at the end of year 2022, a net increase of 1.68%.Total liabilities of the company reached 16,546,751 USD compared with total liabilities of 18,491,908 USD at the end of year 2022, a net decrease of 10.51%. Net ownership equity of the company reached 68,581,243 USD (Including Non-Controlling Interests of 1,032,764 USD) compared with total owner equity of 65,231,302 USD (Including Non-Controlling Interests of 964,992 USD) at the end of year 2022, a net increase of 5.14%.